NLRP3 and kidney disorder: In conclusion, we herein reported that the NLRP3 inflammasome exerted primary effects on CI-AKI by modulating the cell apoptosis, thus provided a novel therapeutic target for kidney diseases, particularly for the treatment of CI-AKI.